Related Experiment Video
Updated: Aug 8, 2026

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI
Published on: November 1, 2014
IgE receptor on human eosinophils (FcERII). Comparison with B cell CD23 and association with an adhesion molecule
C Grangette1, V Gruart, M A Ouaissi
1Centre d'Immunologie et de Biologie Parasitaire, Institut Pasteur Lille, France.
Insights
Researchers characterized IgE Fc receptors (FcERII) on eosinophils and B cells, finding a shared fibronectin-like sequence crucial for IgE binding and cell adhesion. This discovery impacts understanding of immune cell interactions and potential therapeutic targets.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- The IgE Fc receptor (FcERII), also known as CD23, plays a role in immune responses.
- FcERII is found on various immune cells, including B cells and eosinophils.
- The precise function and structural characteristics of FcERII on eosinophils are not fully understood.
Purpose of the Study:
- To characterize and compare the IgE Fc receptor (FcERII) on human eosinophils with that on B cells (CD23).
- To investigate the structural and functional similarities between eosinophil and B cell FcERII.
- To explore the role of a potential cell attachment sequence in FcERII function.
Main Methods:
- Characterization of FcERII using monoclonal antibodies (mAbs) BB10 (anti-eosinophil FcERII) and 135 (anti-CD23).
- Immunoprecipitation and Western blotting to determine molecular weight and IgE binding.
- Flow microfluorometry to assess antibody binding to eosinophils and B cells.
- Inhibition assays using synthetic peptides (RGDS, SDGR) and polyclonal antibodies to study cell adhesion and cytotoxicity.
Main Results:
- Both eosinophil and B cell FcERII share a major component of 45,000-50,000 Mr, recognized by mAbs BB10 and 135.
- Human myeloma IgE binds to the FcERII molecule immunoprecipitated by BB10.
- A fibronectin (Fn)-like sequence containing the L-arginine-L-glycyl-L-aspartyl (RGD) cell attachment domain is present in both eosinophil and B cell FcERII.
- The RGD and SDGR peptides inhibited the binding of BB10 and anti-Fn mAbs to eosinophils and B cells.
- IgE-dependent eosinophil cytotoxicity against parasite targets was significantly inhibited by mAbs and peptides targeting the RGD sequence.
Conclusions:
- Human eosinophil FcERII shares structural and functional similarities with B cell FcERII (CD23).
- A conserved RGD cell attachment sequence is integral to FcERII structure and function, particularly in IgE-mediated eosinophil cytotoxicity.
- This RGD sequence may play a role in eosinophil and B cell adhesion and potentially B cell growth.
Abstract:
IgE FcR (FcERII) on human eosinophils was characterized and compared with FcERII present on B cells (CD23). Two mAb, BB10 (anti-eosinophil FcERII) and 135 (anti-CD23), bound to the major component of FcERII at 45,000 to 50,000 Mr, both on purified hypodense eosinophils and on a B cell line (WIL-2WT). The specific ligand, human myeloma IgE, was able to bind to the molecules immunoprecipitated by BB10. A cross-reactivity between BB10 and a mAb anti-Leishmania gp63, which is a "fibronectin (Fn)-like" molecule, containing the L-arginine-L-glycyl-L-aspartyl (RGD) cell attachment domain indicated the presence of such a sequence in the common structure present on eosinophil and B cell FcERII. The synthetic tetrapeptide RGDS as well as its inverted sequence (SDGR) reduced the binding of BB10 and anti-Fn mAb to eosinophils and B cells. Flow microfluorometry analysis revealed a variable binding of BB10 and anti-Fn mAb to eosinophils purified from different patients, results compatible with recent findings on the inducibility of FcERIIb. The significant inhibition of IgE-dependent cytotoxicity against parasite targets by preincubation of eosinophils with BB10, anti-Fn and anti-CD23 mAb, with anti-RGDS polyclonal antibodies or with the SDGR peptide suggested the requirement of this cell adhesion sequence for the function of low affinity FcERII. The presence of such a sequence in the C-terminal domain of B cell FcERII raised the possibility of its role in B cell adhesion or B cell growth.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Adherens Junctions
Adherens Junctions are Dynamic
The endothelial cells...
Selectins
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

